Cargando…

Plasma Type I IFN Protein Concentrations in Human Tuberculosis

Tuberculosis (TB) remains one of the leading causes of mortality worldwide, and a lack of understanding of basic disease pathogenesis is hampering development of new vaccines and treatments. Multiple studies have previously established a role for type I interferon (IFN) in TB disease. Type I IFNs ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llibre, Alba, Bilek, Nicole, Bondet, Vincent, Darboe, Fatoumatta, Mbandi, Stanley Kimbung, Penn-Nicholson, Adam, Hatherill, Mark, Rozenberg, Flore, Scriba, Thomas J., Duffy, Darragh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713931/ https://www.ncbi.nlm.nih.gov/pubmed/31508378 http://dx.doi.org/10.3389/fcimb.2019.00296

Ejemplares similares

Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Inflammatory Determinants of Differential Tuberculosis Risk in Pre-Adolescent Children and Young Adults
por: Baguma, Richard, et al.
Publicado: (2021)

Blood transcriptional signatures for tuberculosis testing
por: Mendelsohn, Simon C, et al.
Publicado: (2020)

Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses
por: Llibre, Alba, et al.
Publicado: (2022)

Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol
por: Mulenga, Humphrey, et al.
Publicado: (2019)

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
por: Llibre, Alba, et al.
Publicado: (2018)

Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis
por: Mulenga, Humphrey, et al.
Publicado: (2020)

Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy
por: Darboe, Fatoumatta, et al.
Publicado: (2019)

Host transcriptomic signatures of tuberculosis can predict immune reconstitution inflammatory syndrome in HIV patients
por: Mbandi, Stanley Kimbung, et al.
Publicado: (2022)

The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study
por: Mulenga, Humphrey, et al.
Publicado: (2022)

Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Clinical predictors of pulmonary tuberculosis among South African adults with HIV
por: Mendelsohn, Simon C., et al.
Publicado: (2022)

Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection
por: Duffy, Darragh, et al.
Publicado: (2020)

Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy
por: Sumner, Tom, et al.
Publicado: (2019)

Association of IFN-γ +874 A/T SNP and hypermethylation of the -53 CpG site with tuberculosis susceptibility
por: Álvarez, Guadalupe Inés, et al.
Publicado: (2023)

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
por: Penn-Nicholson, Adam, et al.
Publicado: (2020)

Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
por: Scriba, Thomas J, et al.
Publicado: (2021)

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Correction: Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study
por: Penn-Nicholson, Adam, et al.
Publicado: (2019)

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
por: Mendelsohn, Simon C, et al.
Publicado: (2021)

Constitutive IFNα Protein Production in Bats
por: Bondet, Vincent, et al.
Publicado: (2021)

Immune response biomarkers in human and veterinary research
por: Llibre, Alba, et al.
Publicado: (2018)

Secreted Rv1768 From RD14 of Mycobacterium tuberculosis Activates Macrophages and Induces a Strong IFN-γ-Releasing of CD4(+) T Cells
por: Yuan, Chun-Hui, et al.
Publicado: (2019)

Alpha/Beta Interferon (IFN-α/β) Signaling in Astrocytes Mediates Protection against Viral Encephalomyelitis and Regulates IFN-γ-Dependent Responses
por: Hwang, Mihyun, et al.
Publicado: (2018)

Lack of Interferon (IFN) Regulatory Factor 8 Associated with Restricted IFN-γ Response Augmented Japanese Encephalitis Virus Replication in the Mouse Brain
por: Tripathi, Aarti, et al.
Publicado: (2021)

Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania
por: Amelio, Patrizia, et al.
Publicado: (2017)

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease
por: Scriba, Thomas J., et al.
Publicado: (2017)

Superior antiviral activity of IFNβ in genital HSV-1 infection
por: Schmitz, Yasmin, et al.
Publicado: (2022)

Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis
por: Mulenga, Humphrey, et al.
Publicado: (2021)

Potential utility of the Genedrive point-of-care test for HCV RNA detection
por: Llibre, Alba, et al.
Publicado: (2019)

Mycobacterium tuberculosis functional genetic diversity, altered drug sensitivity, and precision medicine
por: Stanley, Sydney, et al.
Publicado: (2022)

Toxoplasma Effector GRA15-Dependent Suppression of IFN-γ-Induced Antiparasitic Response in Human Neurons
por: Bando, Hironori, et al.
Publicado: (2019)

Enhancement of cytokine‐driven NK cell IFN‐γ production after vaccination of HCMV infected Africans
por: Darboe, Alansana, et al.
Publicado: (2017)

Participation of the IL-10RB Related Cytokines, IL-22 and IFN-λ in Defense of the Airway Mucosal Barrier
por: Ahn, Danielle, et al.
Publicado: (2020)

Natural Killer Cells and Host Defense Against Human Rhinoviruses Is Partially Dependent on Type I IFN Signaling
por: van der Heide, Saskia L., et al.
Publicado: (2020)

Staphylococcus aureus β-Hemolysin Up-Regulates the Expression of IFN-γ by Human CD56(bright) NK Cells
por: Guan, Zhangchun, et al.
Publicado: (2021)

Differential levels of IFNα subtypes in autoimmunity and viral infection
por: Bondet, Vincent, et al.
Publicado: (2021)

The SAMHD1 rs6029941 (A/G) Polymorphism Seems to Influence the HTLV-1 Proviral Load and IFN-Alpha Levels
por: Queiroz, Maria Alice Freitas, et al.
Publicado: (2020)

Erratum: Protein kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice
por: Parihar, S P, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_kaqonu7kjmgsn7k4c53tsssenh